AVE
Pharmaceuticals, Biotechnology & Life Sciences
Avecho Biotechnology
- Short interest
- 0.00%
- −0.12 pp 30d
- as of 10 Feb 2025
- Reported shorts
- 29.6K
- Shares on issue
- 3.169B
Avecho Biotechnology (AVE) company profile
Profile, insiders and operations
Company
AI-generated research profile of Avecho Biotechnology
pharmaceuticals
biotechnology
drug delivery
TPM
ASX
Avecho Biotechnology is an Australian innovation-led biotechnology company focused on developing and commercializing human health, animal health, and personal care products. They utilize their proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM) to enhance the solubility and adsorption of drugs and nutrients. Avecho aims to create new market opportunities for healthcare leaders by differentiating their products.
Director trades
6 trades recorded
AVE intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required